HPV vaccine moves into late stage trials

Article Abstract:

This article examines the testing of vaccines that provide protection from human papillomavirus (HPV), as HPV has been linked to cervical cancer. Vaccine research conducted at the National Cancer Institute and the Johns Hopkins School of Public Health has used innovative technology to develop a promising virus-like particle vaccine.

Prevention, Physiological aspects, Cervical cancer, Papillomaviruses, Papillomavirus, Johns Hopkins University. School of Hygiene and Public Health

---

Hepatitis C virus and eliminating post-transfusion hepatitis

Article Abstract:

The quest for an etiological source of a non-A, non-B hepatitis viral infection and its discovery and identification as hepatitis C is discussed. The risk of hepatitis C infection through transfused blood previously screened for non-A, non-B types, was traced to the hepatitis C virus, which paved the way for its near-eradication.

Analysis, Infection, Hepatitis C, Medical screening, Health screening, Blood transfusion, Pathology

---

South African village prepares for first HIV vaccine trial..

Article Abstract:

The Medical Research Council in South Africa will begin its first HIV vaccine trial in February 2001. The author states the Venezuelan equine encephalitis (VEE) virus vaccine will be apart of the trials, and the real challenge in the trials is gaining the support of tribal leaders.

South Africa, Health aspects, HIV (Viruses), HIV, South Africans, Medical Research Council (United Kingdom), Venezuelan equine encephalomyelitis, Equine encephalomyelitis

Similar abstracts:

• Abstracts: Taking control of the situation. Looking for a new direction. Direct to the public
• Abstracts: Molecular targets of gene transfer therapy for HIV infection. Strategies for Long-term Success in the Treatment of HIV Infection
• Abstracts: Estimating prognosis in HIV-1 infection. Importance of routinely taking drug therapy for HIV-1 infection. Cell count, viral load, and clinical outcome in patients with HIV infection after highly active antiretroviral therapy
• Abstracts: Taking school nursing into the community. School for health. School nurses and contraception
• Abstracts: HIV-1 protease inhibitors: a review for clinicians. Acute human immunodeficiency virus type 1 infection. Evaluation of HIV-1 Immunogen, an Immunologic Modifier, Administered to Patients Infected With HIV Having 300 to 549 X [10.sup.6]/L CD4 Cell Counts: A Randomized Controlled Trial

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.